Digital Therapeutics Market worth $17.7 billion | Global Industry Trends, Report 2027

 

According to the new market research report "Digital Therapeutics (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) - Global Forecasts to 2026", the digital therapeutics market is projected to reach USD 13.1 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 31.4% during the forecast period.

Browse in-depth TOC on "Digital Therapeutics (DTx) Market"
157- Tables
27- Figures
204 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724

Key Players:

Prominent players in the Digital Therapeutics Market include Noom (US), Livongo Health (US), Omada Health (US), WellDoc (US), Pear Therapeutics (US), Proteus Digital Health (US), Propeller Health (US), Akili Interactive Labs (US), Better Therapeutics (US), Happify (US), Kaia Health (Germany), Mango Health (US), Click Therapeutics (US), Canary Health (US), Wellthy Therapeutics (India), Cognoa (US), CogniFit (US), Ayogo Health (Canada), Mindstrong Health (US), 2Morrow (US), and Ginger (US).

The Growth in this market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in digital therapeutics.

On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, resistance from traditional healthcare providers, and unstable payment models are challenging the growth of this market.

Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). In 2020, the B2B segment accounted for the largest share of 86.3% of the market. This is attributed to growing awareness among providers, payers, and employers about the benefits of digital therapeutics and the inclination of pharmaceutical companies to integrate digital therapeutics with their drug products.

Based on application, the digital therapeutics market is segmented into preventive and treatment/care-related applications. The treatment/care-related applications segment held the largest share of 82.3% of this market in 2020. The large share of this segment is attributed to the growing incidences of chronic diseases, the rising economic burden of their treatment, and investments in digital therapeutics to encourage the development of cost-effective and scalable treatment platforms for these conditions.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724

Geographical Growth Scenario:

The digital therapeutics market is segmented into North America, Europe, the Asia Pacific, and the RoW. In 2020, North America held the largest share of the market, followed by Europe. The market in North America is also expected to grow at the highest CAGR of 32.2%. Factors such as the influx of new start-ups, increasing investments in digital therapeutics, improvements in the reimbursement structure for digital therapeutics, and government initiatives to support technological advancements drive market growth in this region.

Product launches and collaborations are highly adopted strategies by the global digital therapeutics market players. A few of the recent key market developments are listed below:

In May 2021, Teladoc Health, Inc. launched myStrength Complete, an integrated mental health service provides personalized and targeted care to consumers in a single and comprehensive experience.

In April 2020, Omada Health launched the Omada Insights Lab, its internal initiative that leverages Omada's deep multidisciplinary expertise to transform care delivery and apply learnings into innovative and cost-effective interventions.

In February 2021, Fitbit and Diabetes UK, the leading charity for people affected by diabetes, announced a new three-year partnership. They will work together to educate people on the importance of understanding their health and how leading a healthier and more active lifestyle can play a critical role in preventing type 2 diabetes and managing all types of diabetes.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=51646724

Browse Adjacent Markets: Healthcare IT Market Research Reports & Consulting

Browse Related Reports:

Behavioral Health Software Market by Component (Services, Software), Delivery (Subscription, Ownership), Functionality (Clinical, EHR, CDS, Telehealth, RCM, BI, Administrative, Financial), End User (Hospitals, Clinics) (2022 - 2026)
https://www.marketsandmarkets.com/Market-Reports/behavioral-health-software-market-45953340.html

Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Patch Pump), Diabetes Apps, Service, Data Management Software), Device Type (Handheld & Wearables), End User (Hospitals & Self/home healthcare) - Global Forecast to 2027

https://www.marketsandmarkets.com/Market-Reports/digital-diabetes-management-market-144725893.html